Sibel Doruk

Dr. Sibel Doruk


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2011 in Clinical Chemistry and Laboratory Medicine (CCLM)
Verified
Journal Article
Closed access
SDSibel Doruk
Sibel Doruk
HOHuseyin Ozyurt
Huseyin Ozyurt
HIHandan Inonu
Handan Inonu
UEUnal Erkorkmaz
Unal Erkorkmaz
OSOguzhan Saylan
Oguzhan Saylan
ZSZehra Seyfikli
Zehra Seyfikli
Oxidative stress has a critical role in inflammatory responce against tobacco smoke (TS). Testing exhaled breath condensate (EBC) samples is one of the methods used for assessment of airway inflammation caused by TS. We aimed to investigate oxidative stress in the lungs associated with TS and to evaluate the effect of this stress with pulmonary function tests (PFTs).We included 69 subjects as three groups into the study (Group I; 26 smokers, Group II; 21 passive smokers, Group III; 22 non-smokers without TS exposure). Levels of malondialdehyde (MDA), 8-hydroxydeoxyguanosine (8-OHdG), nitrite/nitrate ;ibindex of nitric oxide (NO) production;ic, vitamin C, superoxide dismutase (SOD), and glutathione peroxidase (GSH-Px) were measured in EBC samples collected using a condenser and PFTs were performed.The levels of MDA, 8-OHdG, SOD and GSH-Px were higher in smokers. NO levels gradually increased from Group I to Group III. MDA levels were lower in Group III than Group II. The levels of vitamin C were similar in all groups. We determined negative correlation between 8-OHdG levels and forced expiratory volume in one second (FEVTS exposure affected the balance between oxidative stress and antioxidant capacity of lungs. Preventing environmental TS exposure might decrease oxidative damage. Increased levels of 8-OHdG and SOD levels could be assessed as an early sign of airway damage.

1 November 2012
Verified
Journal Article
Open access
Ahmet Cemal PazarlıAhmet Cemal Pazarlı
Ahmet Cemal Pazarlı
HKHandan Inonu Koseoglu
Handan Inonu Koseoglu
SDSibel Doruk
Sibel Doruk
SSSemsettin Sahin
Semsettin Sahin
IEIlker Etikan
Ilker Etikan
BBBahadir Berktas
Bahadir Berktas
Acute exacerbations of chronic obstructive pulmonary disease (AeCOPD) are important causes of morbidity and mortality. In this study, we analyzed procalcitonin (PCT) levels in AeCOPD and stable period of COPD in order to evaluate usage of PCT in the prediction of the severity of AeCOPD, and its value on the planing of noninvasive positive pressure ventilation (NPPV). In this cross sectional study (2009-2010) 118 COPD patients were enrolled, 68 of them (58%) were in acute exacerbations (case group). The others had stabile COPD and they were defined as control group. In case group the mean levels of PCT (0.19 ± 0.02) C-Reactive Protein (44.7 ± 5.92), erythrocyte sedimentation rate (28.4 ± 2.65), white blood cell (9.4 ± 0.43) and %neutrophils (69.9 ± 1.22) were significantly higher than controls (P = 0.0001). There was no difference between PCT levels based on stages of COPD. There were significiant differences in mean PCT levels according to type and severity of AeCOPD. Mean PCT level in hospitalized patients receiving NPPV was 0.36 ng/ml, while it was 0.15 ng/ml for those treated without NPPV (P = 0.0001). PCT cut-off value for NPPV indication was determined to be 0.10 ng/ml. PCT levels were found to be higher in AeCOPD patients than in stable COPD patients, as expected. Also mean PCT levels increased especially in cases with severe AeCOPD and those receiving NPPV among them. In the present study, we determined a cut off value of PCT as 0.10 ng/ml as a predictor of necessity of NPPV in AeCOPD.

14 July 2021 in Turkish Thoracic Journal
Verified
Journal Article
Closed access
FGFiliz Guldaval
Filiz Guldaval
GEGülru Erbay
Gülru Erbay
SDSibel Doruk
Sibel Doruk
GKGulistan Karadeniz
Gulistan Karadeniz
AAAYSU AYRANCI
AYSU AYRANCI
CACeyda Anar
Ceyda Anar
Chronic obstructive pulmonary disease,smoker,non-smoker

1 January 2013 in Clinical Chemistry and Laboratory Medicine (CCLM)
Verified
Journal Article
Closed access
DCDeniz Celik
Deniz Celik
SDSibel Doruk
Sibel Doruk
HKHandan Inonu Koseoglu
Handan Inonu Koseoglu
SSSemsettin Sahin
Semsettin Sahin
SCSerhat Celikel
Serhat Celikel
UEUnal Erkorkmaz
Unal Erkorkmaz
Cysteinyl leukotrienes (CysLTs) are among important inflammatory mediators in asthma pathogenesis. In this study, we aimed to determine leukotriene D₄ (LTD₄) and leukotriene E₄ (LTE₄) levels in exhaled breath condensate (EBC) in asthmatics and to evaluate the effect of smoking upon CysLTs levels and to speculate the importance of adding leukotriene receptor antagonists in smoking asthmatics. A total of 88 participants were included in the study. Of them, 59 were asthmatics; 30 of the 59 asthmatics were smokers (Group I) and the others were non-smokers (Group II). As a control group (Group III), 29 healthy non-smokers were enrolled. EBC samples were collected (EcoScreen, Jaeger, Hoechberg, Germany) and pulmonary function tests (PFTs) were performed in each case, and an asthma control questionnaire (ACQ) was completed by the asthmatics. LTD₄ and LTE₄ levels in EBC samples were analyzed by using ELISA. LTD₄ levels were found to be higher in Group I than other groups and similar in Group II and Group III. LTE₄ levels were lower in Group III than other groups and similar in Group I and Group II. PFTs were different between Group I and Group III and there was a significant negative correlation between LTE₄ levels and forced expiratory volume in one second and forced vital capacity ratio in Group I. LTD₄, but not LTE₄, concentrations in EBC were higher in asthmatic smokers than asthmatic nonsmokers. LTE₄ concentrations in EBC were higher in asthmatics than healthy non-smokers. In smoking asthmatics usage of agents that block the effects of LTD₄ can be beneficial; however, new clinical studies are required.

1 December 2013
Verified
Journal Article
Open access
ECEmel Ceylan
Emel Ceylan
SDSibel Doruk
Sibel Doruk
SGSebahat Genc
Sebahat Genc
AOAyşe Aydan Ozkutuk
Ayşe Aydan Ozkutuk
FKFisun Karadag
Fisun Karadag
ACArif Hikmet Cımrın
Arif Hikmet Cımrın
The effect of mold fungi to allergic sensitization is not well-known. We aimed to evaluate the role of molds in the relation between indoor environment and atopy in asthmatics. The air samples obtained from 66 stable asthmatics and 35 control subject's houses were sprayed into Sabouraud dextrose agar. Allergy skin testing were performed in both groups. The temperature and humidity of each house were measured. The incidence of atopy was similar in cases (59.1%) and controls (51.4%). The average amount of mold was 35.9 CFU/m3 and 34.3 CFU/m3, respectively. The number of household residents was positively correlated with the amount of molds. There was no difference in the amount of mold with respect to dosage of inhaler corticosteroids as well as symptom levels in asthmatics. The most frequently encountered allergens were Dermatophagoides farinae/Dermatophagoides pteronyssinus, grass/weeds and molds. Spending childhood in a village was more common among atopics. Living environment during the childhood might affect atopy and asthma. Based on the identification of molds as the second most frequent allergen after mites in our study population, assessment of mold sensitization as well as in forming patients about ways to avoid them seem likely to contribute to the effective management of uncontrolled asthma.

1 January 2016 in Turkiye Klinikleri Archives of Lung
Verified
Journal Article
Closed access
SDSibel Doruk
Sibel Doruk
HKHandan İnönü Köseoğlu
Handan İnönü Köseoğlu
GYGülgün Yeni̇şehi̇rli̇
Gülgün Yeni̇şehi̇rli̇
IEİlker Eti̇kan
İlker Eti̇kan
DSDursun Ali Sağlam
Dursun Ali Sağlam
ÖGÖzgür Günal
Özgür Günal